TickerFacts.

Mangoceuticals, Inc. (MGRX): Net Income

Annual figures by period end, from SEC filings.

-$20.64M
Year ended 2025-12-31
-$15.10M
Trailing 12 months to 2026-06-30
2022-12-31: -$2.00M2023-12-31: -$9.21M2024-12-31: -$8.71M2025-12-31: -$20.64M-$20.64M
2022-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31-$20.64Mn/m2026-04-01, From 2025-01-01
2024-12-31-$8.71Mn/m2026-04-01, From 2024-01-01
2023-12-31-$9.21Mn/m2025-03-20, From 2023-01-01
2022-12-31-$2.00Mn/a2024-04-01, From 2022-01-01

Net Income at similar companies

Companies with the same SEC industry code (Services-Misc Health & Allied Services, NEC), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Mangoceuticals, Inc. (MGRX)2025-12-31-$20.64Mn/m
BioRestorative Therapies, Inc. (BRTX)2025-12-31-$14.24Mn/m
Charming Medical Ltd (MCTA)2026-03-31-$22.6Kn/m
Pacific Health Care Organization Inc (PFHO)2025-12-31$1.39M+57.0%
Marpai, Inc. (MRAI)2025-12-31-$16.56Mn/m
Cryo Cell International Inc (CCEL)2025-11-30-$2.43Mn/m
Viemed Healthcare, Inc. (VMD)2025-12-31$14.93M+32.6%
Sotera Health Co (SHC)2025-12-31$77.95M+75.6%
Progyny, Inc. (PGNY)2025-12-31$58.52M+7.7%

Compare MGRX, BRTX, MCTA, PFHO side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗